Go Pro
→ It’s not about Greenland (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$176.18
-2.0%		$172.11
$127.59
▼
$193.07
$49.54B0.211.55 million shs1.70 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.03
-4.3%		$47.04
$42.20
▼
$105.72
$65.16B0.5718.73 million shs22.67 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$86.70
+0.6%		$89.36
$72.30
▼
$96.29
$49.62B0.852.63 million shs2.31 million shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$24.62
-1.6%		$26.69
$23.85
▼
$33.44
$24.59B0.76651,389 shs817,233 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
+0.32%-4.09%+0.19%+22.06%-5.58%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+0.08%-6.94%-10.67%-4.61%-58.36%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
-0.53%-4.98%-6.23%+0.62%+8.06%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-1.03%-5.13%-7.04%-4.23%-11.07%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$176.18
-2.0%		$172.11
$127.59
▼
$193.07
$49.54B0.211.55 million shs1.70 million shs
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$43.03
-4.3%		$47.04
$42.20
▼
$105.72
$65.16B0.5718.73 million shs22.67 million shs
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$86.70
+0.6%		$89.36
$72.30
▼
$96.29
$49.62B0.852.63 million shs2.31 million shs
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$24.62
-1.6%		$26.69
$23.85
▼
$33.44
$24.59B0.76651,389 shs817,233 shs
Don't Wait for the OpenAI IPO Cover
Don't Wait for the OpenAI IPO

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
+0.32%-4.09%+0.19%+22.06%-5.58%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
+0.08%-6.94%-10.67%-4.61%-58.36%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
-0.53%-4.98%-6.23%+0.62%+8.06%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
-1.03%-5.13%-7.04%-4.23%-11.07%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
2.41
Hold$187.676.52% Upside
Boston Scientific Corporation stock logo
BSX
Boston Scientific
2.71
Moderate Buy$71.4666.07% Upside
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
2.74
Moderate Buy$100.2715.66% Upside
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest PHG, BSX, EW, and BDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$60.00 ➝ $56.00
8/31/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Bank of America Corporation logo
Bank of America
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$185.00 ➝ $200.00
8/25/2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
TD Cowen logo
TD Cowen
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$56.00
8/13/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy
8/13/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$180.00 ➝ $190.00
8/13/2026
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D+)
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$195.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$175.00 ➝ $180.00
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Perform ➝ Hold
8/7/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$198.00 ➝ $204.00
(Data available from 9/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$21.84B2.22$22.62 per share7.79$88.58 per share1.99
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$20.07B3.11$3.86 per share11.14$16.49 per share2.61
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$6.07B8.23$2.87 per share30.22$17.81 per share4.87
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$20.17B1.20$3.04 per share8.09$12.91 per share1.91
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$1.68B$3.3253.0713.3112.674.52%14.79%6.93%11/5/2026 (Estimated)
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$2.90B$2.4717.4212.581.0417.50%19.28%10.89%10/28/2026 (Estimated)
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$1.07B$1.7449.8225.572.2615.43%15.68%12.05%10/29/2026 (Estimated)
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$1.01B$1.3618.1412.8910.386.30%14.38%5.96%11/3/2026 (Estimated)

Latest PHG, BSX, EW, and BDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q3 2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$3.14$3.23+$0.09$1.37$4.89 billion$4.98 billion
7/29/2026Q2 2026
Boston Scientific Corporation stock logo
BSX
Boston Scientific
$0.83$0.86+$0.03$0.61$5.38 billion$5.44 billion
7/27/2026Q2 2026
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.40$0.57+$0.17$0.46$4.91 billion$4.98 billion
7/23/2026Q2 2026
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
$0.7430$0.78+$0.0370$0.42$1.70 billion$1.74 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
$4.202.38%+5.65%126.51%53 Years
Boston Scientific Corporation stock logo
BSX
Boston Scientific
N/AN/AN/AN/AN/A
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
N/AN/AN/AN/AN/A
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
$0.843.41%-13.87%61.76%N/A

Latest PHG, BSX, EW, and BDX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
quarterly$1.052.33%9/9/20269/9/20269/30/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.55
0.87
0.51
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.43
1.24
0.74
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.06
4.52
3.77
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
0.55
1.26
0.82

Institutional Ownership

CompanyInstitutional Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
86.97%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
89.07%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
79.46%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
13.67%

Insider Ownership

CompanyInsider Ownership
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
0.40%
Boston Scientific Corporation stock logo
BSX
Boston Scientific
0.34%
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
0.31%
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Becton, Dickinson and Company stock logo
BDX
Becton, Dickinson and Company
72,000275.54 million274.44 millionOptionable
Boston Scientific Corporation stock logo
BSX
Boston Scientific
59,0001.45 billion1.44 billionOptionable
Edwards Lifesciences Corporation stock logo
EW
Edwards Lifesciences
16,000575.80 million574.02 millionOptionable
Koninklijke Philips N.V. stock logo
PHG
Koninklijke Philips
65,340982.89 millionN/AOptionable

Recent News About These Companies

Philips Expands Women's Health Ultrasound Portfolio With New Transducer
September 7 at 1:21 PM  |  zacks.comhttps://www.zacks.com/stock/news/2986024/philips-expands-women-s-health-ultrasound-portfolio-with-new-transducer?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2986024
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
September 4, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2985160/philips-shares-ai-tool-data-for-mitral-regurgitation-assessment-at-esc?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2985160
Philips launches advanced eV14-2v transducer to strengthen women’s health ultrasound portfolio
September 3, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/philips-launches-advanced-ev14-2v-transducer-to-strengthen-womens-health-ultrasound-portfolio?utm_source=marketbeat.com&utm_medium=referral
Philips advances women's health ultrasound with new single-transducer solution
September 3, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/03/3355984/0/en/philips-advances-women-s-health-ultrasound-with-new-single-transducer-solution.html
Koninklijke Philips N.V. (NYSE:PHG) Receives Average Rating of "Hold" from Analysts
September 2, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30997649
Koninklijke Philips N.V. (NYSE:PHG) Receives Average Recommendation of "Hold" from Analysts
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-koninklijke-philips-nv-nyse-phg-receives-average-recommendation-of-hold-from-analysts-2026-08-28/
Philips and Imricor unveil turnkey MR-guided cardiac intervention lab
August 27, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/philips-and-imricor-unveil-turnkey-mr-guided-cardiac-intervention-lab?utm_source=marketbeat.com&utm_medium=referral
Philips and Imricor launch cardiac interventional MR lab solution, expanding longstanding collaboration
August 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/27/3352083/0/en/philips-and-imricor-launch-cardiac-interventional-mr-lab-solution-expanding-longstanding-collaboration.html
Philips Wins ARPA-H Funding to Advance AI-Driven Robotic Stroke Care
August 26, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/philips-wins-arpa-h-funding-to-advance-ai-driven-robotic-stroke-care?utm_source=marketbeat.com&utm_medium=referral
Philips selected for ARPA-H program to advance AI-enabled robotic stroke care
August 26, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/26/3351416/0/en/philips-selected-for-arpa-h-program-to-advance-ai-enabled-robotic-stroke-care.html
Philips Launches Healthcare Sector’s First EU Green Bond Under New Standard
August 24, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/philips-launches-healthcare-sectors-first-eu-green-bond-under-new-standard?utm_source=marketbeat.com&utm_medium=referral
Philips prices EU green bond for EUR 650M
August 24, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/24/3350129/0/en/philips-prices-eu-green-bond-for-eur-650m.html
Bank of America Corp DE Purchases 50,124 Shares of Koninklijke Philips N.V. $PHG
August 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-america-corp-de-purchases-50124-shares-of-koninklijke-philips-nv-phg-2026-08-20/
Koninklijke Philips N.V. (NYSE:PHG) Short Interest Update
August 18, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/koninklijke-philips-nv-nysephg-short-interest-update-2026-08-18/
Koninklijke Philips (NYSE:PHG) Raised to Hold at Zacks Research
August 15, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/koninklijke-philips-nysephg-raised-to-hold-at-zacks-research-2026-08-15/
Philips, Shell targeted by hacking group
August 13, 2026  |  reuters.comhttps://www.reuters.com/legal/government/philips-shell-targeted-by-hacking-group-2026-08-13/
Koninklijke Philips N.V. $PHG Stock Position Decreased by Diversified Management Inc.
August 12, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-koninklijke-philips-nv-phg-stock-position-decreased-by-diversified-management-inc-2026-08-12/
Agnelli family's Exor can raise Philips stake to 22% under updated agreement
August 11, 2026  |  reuters.comhttps://www.reuters.com/legal/transactional/agnelli-familys-exor-can-raise-philips-stake-22-under-updated-agreement-2026-08-11/
Philips deepens wearable partnerships to extend continuous patient monitoring from hospital to home
August 6, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/philips-deepens-wearable-partnerships-to-extend-continuous-patient-monitoring-from-hospital-to-home?utm_source=marketbeat.com&utm_medium=referral
Philips expands open patient monitoring ecosystem to help health systems keep sight of patients beyond the bedside
August 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340318/0/en/philips-expands-open-patient-monitoring-ecosystem-to-help-health-systems-keep-sight-of-patients-beyond-the-bedside.html
Speech Processing Solutions Launches Philips SpeechLive Legal AI Assistant for Faster, More Accurate Legal Document Creation
August 5, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260805997413/en/speech-processing-solutions-launches-philips-speechlive-legal-ai-assistant-for-faster-more-accurate-legal-document-creation/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
A Tesla concept vehicle with illuminated front light bar drives on a road against a city skyline at dusk.
Tesla’s Robotaxi Launch Wasn’t the Moment Investors Expected
By Sam Quirke | September 8, 2026
IonQ logo displayed within an illuminated glass chamber surrounded by a futuristic space-themed backdrop.
IonQ’s Space Contract Points to a New Frontier for Quantum Investors
By Nathan Reiff | August 19, 2026
Illustrated Broadcom semiconductor chip on a circuit board with glowing red data-connection lines.
Marvell Takes a Shot a Broadcom's Throne With Google Deal
By Leo Miller | August 24, 2026
Foldable Apple smartphone displayed on a table with a lit Apple logo and city skyline in the background.
Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
By Sam Quirke | August 30, 2026
Illustration of an Nvidia chip connected by a glowing dollar-sign loop to a SpaceX rocket on a launch pad.
NVIDIA Reveals $21 Billion SpaceX Stake: Signal of Confidence or Circular Financing?
By Leo Miller | August 25, 2026
Becton, Dickinson and Company stock logo

Becton, Dickinson and Company NYSE:BDX

$176.18 -3.62 (-2.01%)
Closing price 03:59 PM Eastern
Extended Trading
$176.35 +0.17 (+0.10%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Boston Scientific stock logo

Boston Scientific NYSE:BSX

$43.03 -1.93 (-4.29%)
Closing price 03:59 PM Eastern
Extended Trading
$43.24 +0.20 (+0.47%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences stock logo

Edwards Lifesciences NYSE:EW

$86.70 +0.52 (+0.60%)
Closing price 03:59 PM Eastern
Extended Trading
$86.60 -0.09 (-0.11%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Koninklijke Philips stock logo

Koninklijke Philips NYSE:PHG

$24.62 -0.40 (-1.60%)
Closing price 03:59 PM Eastern
Extended Trading
$24.62 +0.00 (+0.02%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas